Mean platelet volume as a predictor of pulmonary hypertension in patients with stable COPD

References

• Burney PGJ, Patel J, Newson R, Minelli C, Naghavi M. Global and regional trends in COPD mortality, 1990–2010. Eur Respir J. 2015;45:1239–1247. doi:10.1183/09031936.0014241425837037
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TAR, Patel IS, et al. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest. 2005;128:1995–2004. doi:10.1378/chest.128.4.199516236847
   PubMed Web of Science ®Google Scholar
• Galiè N, Humbert M, Vachiery JL, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2015;37:67–119.26320113
   PubMed Web of Science ®Google Scholar
• Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54:S43–S54. doi:10.1016/j.jacc.2009.04.01219555858
   PubMed Web of Science ®Google Scholar
• Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53:1801913. doi:10.1183/13993003.01184-201830545968
   PubMed Web of Science ®Google Scholar
• Hoeper MM, Humbert M. The new haemodynamic definition of pulmonary hypertension: evidence prevails, finally! Eur Respir J. 2019;53:1900038. doi:10.1183/13993003.01184-201830923177
   PubMed Web of Science ®Google Scholar
• Gibbs JSR, Torbicki A. Proposed new pulmonary hypertension definition: is 4 mm (Hg) worth re-writing medical textbooks? Eur Respir J. 2019;53:1900197. doi:10.1183/13993003.01184-201830923179
   PubMed Web of Science ®Google Scholar
• Thabut G, Dauriat G, Stern JB, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest. 2005;127:1531–1536. doi:10.1378/chest.127.5.153115888824
   PubMed Web of Science ®Google Scholar
• Cuttica MJ, Kalhan R, Shlobin OA, et al. Categorization and impact of pulmonary hypertension in patients with advanced COPD. Respir Med. 2010;104:1877–1882. doi:10.1016/j.rmed.2010.05.00920547449
   PubMed Web of Science ®Google Scholar
• Vernooy JH, Küçükaycan M, Jacobs JA, Chavannes NH, Buurman WA, Dentener MA. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med. 2002;166:1218–1224. doi:10.1164/rccm.220202312403691
   PubMed Web of Science ®Google Scholar
• Maclay JD, McAllister DA, Mills NL, et al. Vascular dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180:513–520. doi:10.1164/rccm.200903-0414OC19542477
   PubMed Web of Science ®Google Scholar
• Alessandri C, Basili S, Violi F, et al. Hypercoagulability state in patients with chronic obstructive pulmonary disease. Thromb Haemost. 1994;72:343–346. doi:10.1055/s-0038-16488687855781
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Syndercombe-Court D, Tan KC. Increased platelet aggregate formation in patients with chronic airflow obstruction and hypoxaemia. Thorax. 1991;46:504–507.1877038
   PubMed Web of Science ®Google Scholar
• Shen D, Wang Y. Effects of hypoxia on platelet activation in pilots. Aviat Space Environ Med. 1994;65:646–648.7945133
   PubMedGoogle Scholar
• Malerba M, Clini E, Malagola M, Avanzi GC. Platelet activation as a novel mechanism of atherothrombotic risk in chronic obstructive pulmonary disease. Expert Rev Hematol. 2013;6(4):475–483. doi:10.1586/17474086.2013.81483523991933
   PubMed Web of Science ®Google Scholar
• Meyer T, Amaya M, Desai H, et al. Human platelets contain and release TWEAK. Platelets. 2010;21(7):571–574. doi:10.3109/09537104.2010.51240320849210
   PubMed Web of Science ®Google Scholar
• Jasiewicz M, Moniuszko M, Pawlak D, et al. Activity of the kynurenine pathway and its interplay with immunity in patients with pulmonary arterial hypertension. Heart. 2016;102:230–237. doi:10.1136/heartjnl-2015-30858126769378
   PubMed Web of Science ®Google Scholar
• Jasiewicz M, Knapp M, Waszkiewicz E, et al. Enhanced IL-6 trans-signaling in pulmonary arterial hypertension and its potential role in disease-related systemic damage. Cytokine. 2015;76(2):187–192. doi:10.1016/j.cyto.2015.06.01826163998
   PubMed Web of Science ®Google Scholar
• Humbert M, Monti G, Brenot F, et al. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med. 1995;151(5):1628–1631. doi:10.1164/ajrccm.151.5.77356247735624
   PubMed Web of Science ®Google Scholar
• Jasiewicz M, Kowal K, Kowal-Bielecka O, et al. Serum levels of CD163 and TWEAK in patients with pulmonary arterial hypertension. Cytokine. 2014;66:40–45. doi:10.1016/j.cyto.2013.12.01324548423
   PubMed Web of Science ®Google Scholar
• Bansal R, Gupta HL, Goel A, Yadav M. Association of increased platelet volume in patients of chronic obstructive pulmonary disease : clinical implications. JIACM. 2002;3(2):169–172.
   Google Scholar
• Kazimierczyk R, Kamiński K. The role of platelets in the development and progression of pulmonary arterial hypertension. Adv Med Sci. 2018;63(2):312–316. doi:10.1016/j.advms.2018.04.01329885631
   PubMed Web of Science ®Google Scholar
• Merolla M, Nardi MA, Hu L, Rockman CB, Berger JS. Platelet size is an excellent surrogate for increased platelet activity. JACC. 2011;57(15):E1600. doi:10.1016/S0735-1097(11)61600-8
   Web of Science ®Google Scholar
• Bancroft AJ, Abel EW, Mclaren M, Belch J. Mean platelet volume is a useful parameter: a reproducible routine method using a modified Coulter thrombocytometer. Platelets. 2000;11(7):379–387.11132104
   PubMed Web of Science ®Google Scholar
• Dastjerdi MS, Emami T, Najafian A, Amini M. Mean platelet volume measurement, EDTA or citrate? Hematology. 2006;11(5):317–319. doi:10.1080/1024533060095416317607580
   PubMed Web of Science ®Google Scholar
• Koutsokera A, Kiropoulos TS, Nikoulis DJ, et al. Clinical, functional and biochemical changes during recovery from COPD exacerbations. Respir Med. 2009;103(6):919–926. doi:10.1016/j.rmed.2008.12.00619121927
   PubMed Web of Science ®Google Scholar
• Kaushal M, Shah PS, Shah AD, Francis SA, Patel NV, Kothari KK. Chronic obstructive pulmonary disease and cardiac comorbidities: a cross-sectional study. Lung India. 2016;33(4):404–409. doi:10.4103/0970-2113.18487427578933
   PubMedGoogle Scholar
• Oswald-Mammosser M, Weitzenblum E, Quoix E, et al. Prognostic factors in COPD patients receiving long-term oxygen therapy: importance of pulmonary artery pressure. Chest. 1995;107(5):1193–1198. doi:10.1378/chest.107.5.11937750305
   PubMed Web of Science ®Google Scholar
• Maula F, Khan MN, Adil M, et al. Echocardiographic findings in chronic obstructive pulmonary disease (COPD) patients. Pak J Chest Med. 2015;19(1).
   Google Scholar
• Ali ER. Role of mean platelet volume in patients with chronic obstructive pulmonary disease. Egypt J Bronchol. 2017;10:251–260. doi:10.4103/1687-8426.193635
   Google Scholar
• Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J. 2008;32:1371–1385. doi:10.1183/09031936.0001560818978137
   PubMed Web of Science ®Google Scholar
• Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5:549–555. doi:10.1513/pats.200709-148ET18453370
   PubMedGoogle Scholar
• Gajanan K, Pophale H. Retrospective study of frequency of pulmonary hypertension in chronic obstructive pulmonary disease (COPD). Indian J Appl Res. 2014;4(12):400–401.
   Google Scholar
• Naeije R. Pulmonary hypertension and Right heart failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2:20–22. doi:10.1513/pats.200407-037MS16113464
   PubMedGoogle Scholar
• Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Fessler HE. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med. 2002;166:314–322. doi:10.1164/rccm.210702712153963
   PubMed Web of Science ®Google Scholar
• Arcasoy SM, Christie JD, Ferrari VA, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med. 2003;167(5):735–740. doi:10.1164/rccm.200210-1130OC12480614
   PubMed Web of Science ®Google Scholar
• Gologanu D, Stanescu C, Ursica T, Balea MI, Ionita D, Bogdan MA. Prevalence and characteristics of pulmonary hypertension associated with COPD-A pilot study in patients referred to a pulmonary rehabilitation program clinic. Maedica. 2013;8(3):243–248.24371492
   PubMedGoogle Scholar
• Ulasli SS, Ozyurek BA, Yilmaz EB, Ulubay G. Mean platelet volume as an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease. Pol Arch Med Wewn. 2012;122(6):284–290.22576316
   PubMed Web of Science ®Google Scholar
• Rostango C, Prisco D, Boddi M, Poggesi L. Evidence for local platelet activation in pulmonary vessels in patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease. Eur Respir J. 1991;4:147–151.1828437
   PubMed Web of Science ®Google Scholar
• Nakstad B, Lyeberg T, Skjønsberg OH, Boye NP. Local activation of the coagulation and fibrinolysis system in lung disease. Thromb Res. 1990;57(6):827–838.2382254
   PubMed Web of Science ®Google Scholar
• Segall M, Goetzman B. Hypoxic pulmonary hypertension: changes in platelet size and number. Amer J Perinatol. 1991;8(5):300–303. doi:10.1055/s-2007-9994031760062
   PubMed Web of Science ®Google Scholar
• Lopes AAB, Maeda NY, Ebaid M, Chamone DAF. Aggregation of platelets in whole blood from children with pulmonary hypertension. Int J Cardiol. 1990;28(2):173–178. doi:10.1016/0167-5273(90)90058-D2394522
   PubMed Web of Science ®Google Scholar
• Can MM, Tanboga IH, Demircan HC, et al. Enhanced hemostatic indices in patients with pulmonary arterial hypertension: an observational study. Thromb Res. 2010;126(4):280–282. doi:10.1016/j.thromres.2010.06.02020673969
   PubMed Web of Science ®Google Scholar
• Varol E, Uysal BA, Ozaydin M. Platelet indices in patients with pulmonary arterial hypertension. Clin Appl Thromb-Hem. 2011;17(6):E171–E174. doi:10.1177/1076029610394438
   Web of Science ®Google Scholar
• Güvenc TS, Erer HB, Ilhan S, et al. Comparison of mean platelet volume values among different causes of pulmonary hypertension. Cardiol J. 2012;19(2):180–187.22461052
   PubMed Web of Science ®Google Scholar
• Arslan D, Cimen D, Guvenc O, Kaya F, Sert A, Oran B. Platelet distribution width and mean platelet volume in children with pulmonary arterial hypertension secondary to congenital heart disease with left-to-right shunt: new indices of severity? Pediatr Cardiol. 2013;34:1013–1016. doi:10.1007/s00246-012-0600-523254645
   PubMed Web of Science ®Google Scholar
• Zhang M, Li Y, Zhang J, et al. Mean platelet volume is elevated in exacerbated and convalescent COPD patients. Clinica Chimica Acta. 2015;451:227–231. doi:10.1016/j.cca.2015.10.001
   PubMed Web of Science ®Google Scholar
• Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med. 2008;178(4):332–338. doi:10.1164/rccm.200712-1869OC18511702
   PubMed Web of Science ®Google Scholar
• D’Alto M, Romeo E, Argiento P, et al. Accuracy and precision of echocardiography versus right heart catheterization for the assessment of pulmonary hypertension. Int J Cardiol. 2013;168(4):4058–4062. doi:10.1016/j.ijcard.2013.07.00523890907
   PubMed Web of Science ®Google Scholar
• Janda S, Shahidi N, Gin K, Swiston J. Diagnostic accuracy of echocardiography for pulmonary hypertension: a systematic review and meta-analysis. Heart. 2011;97(8):612–622. doi:10.1136/hrt.2010.21208421357375
   PubMed Web of Science ®Google Scholar